Collegium Pharmaceutical
COLL
#5159
Rank
โ‚น138.66 B
Marketcap
โ‚น4,387
Share price
-0.50%
Change (1 day)
71.42%
Change (1 year)

Revenue for Collegium Pharmaceutical (COLL)

Revenue in 2025 (TTM): โ‚น65.51 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น68.31 Billion. In 2024 the company made a revenue of โ‚น54.16 Billion an increase over the revenue in the year 2023 that were of โ‚น47.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Collegium Pharmaceutical from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น65.51 B20.94%
2024 โ‚น54.16 B14.81%
2023 โ‚น47.18 B22.9%
2022 โ‚น38.39 B86.29%
2021 โ‚น20.60 B-9.11%
2020 โ‚น22.67 B7.16%
2019 โ‚น21.15 B7.91%
2018 โ‚น19.60 B978.37%
2017 โ‚น1.81 B1463.78%
2016 โ‚น0.11 B
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agile Therapeutics
AGRX
โ‚น1.94 B-97.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น328.84 B 381.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
United Therapeutics
UTHR
โ‚น282.28 B 313.23%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
โ‚น0.94 B-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA